Institutional Ownership Mereo Biopharma Group PLC (MREO)
This table provides information about the institutional ownership of Mereo Biopharma Group PLC (MREO). We have compiled data on the 99 institutions that hold shares in the stock, with a total of 116 Million shares, which have been reported (via 13F filing form) to have a value of $333 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
17,122,563
shares
|
$49.1 Million
0.03% of portfolio
|
Q4 2024
Added 38.69%
|
|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
15,307,347
shares
|
$43.9 Million
0.89% of portfolio
|
Q2 2024
Added 12.94%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
9,599,170
shares
|
$27.5 Million
1.34% of portfolio
|
Q4 2024
Added 0.68%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
8,715,013
shares
|
$25 Million
0.06% of portfolio
|
Q4 2024
Reduced 10.29%
|
|
Mangrove Partners
New York, NY |
Feb 14, 2025 Q4 2024 |
8,636,485
shares
|
$24.8 Million
4.71% of portfolio
|
Q4 2024
Reduced 1.07%
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Feb 14, 2025 Q4 2024 |
6,710,429
shares
|
$19.3 Million
0.58% of portfolio
|
Q2 2024
New holding
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
5,097,779
shares
|
$14.6 Million
1.07% of portfolio
|
Q3 2024
Added 15.82%
|
|
Alkeon Capital Management LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
4,698,100
shares
|
$13.5 Million
0.03% of portfolio
|
Q2 2024
Added 10.85%
|
|
683 Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
4,550,000
shares
|
$13.1 Million
1.14% of portfolio
|
Q4 2024
Reduced 6.18%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
3,965,432
shares
|
$11.4 Million
0.01% of portfolio
|
Q4 2024
Reduced 26.49%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
3,554,234
shares
|
$10.2 Million
0.0% of portfolio
|
Q4 2024
Added 51.38%
|
|
Clearline Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,217,894
shares
|
$9.24 Million
1.64% of portfolio
|
Q4 2024
Reduced 0.81%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
2,648,140
shares
|
$7.6 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Tejara Capital LTD
London, X0 |
Feb 10, 2025 Q4 2024 |
2,317,085
shares
|
$6.65 Million
5.31% of portfolio
|
Q4 2024
Reduced 18.12%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,119,852
shares
|
$6.08 Million
0.0% of portfolio
|
Q4 2024
Added 5.55%
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
1,551,082
shares
|
$4.45 Million
0.08% of portfolio
|
Q3 2021
Added 48.46%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,189,471
shares
|
$3.41 Million
0.01% of portfolio
|
Q4 2024
Reduced 8.88%
|
|
Great Point Partners LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,150,000
shares
|
$3.3 Million
2.65% of portfolio
|
Q4 2024
New holding
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,085,512
shares
|
$3.12 Million
0.13% of portfolio
|
Q4 2024
Added 33.07%
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$2.87 Million
0.31% of portfolio
|
Q3 2024
Reduced 43.66%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
964,900
shares
|
$2.77 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Tema Etfs LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
890,548
shares
|
$2.56 Million
1.29% of portfolio
|
Q4 2024
New holding
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
866,317
shares
|
$2.49 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.77%
|
|
Neos Investment Management LLC
Westport, CT |
Feb 12, 2025 Q4 2024 |
824,603
shares
|
$2.37 Million
0.07% of portfolio
|
Q4 2024
Reduced 1.27%
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
786,953
shares
|
$2.26 Million
0.19% of portfolio
|
Q4 2024
Reduced 7.08%
|